Skip to content

Clinical trials

Terminated Leukemia, Myeloid, Acute trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Status: Terminated Country / region: Japan Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20161
20171
20183
20203
20213
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Amgen3
Gilead Sciences2
Novartis Pharmaceuticals2
Astex Pharmaceuticals, Inc.1
Celgene Corporation1
Servier Bio-Innovation LLC1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute15
Multiple Myeloma4
Myelodysplastic Syndromes4
Hematologic Neoplasms3
Lymphoma, Non-Hodgkin3
Neoplasms3
Recurrence3
Leukemia, Myelomonocytic, Chronic2
Carcinoma, Non-Small-Cell Lung1
Hodgkin Disease1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.